Search Results - "VUKCEVIC, Mirko" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous Sclerosis

mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous Sclerosis

by Costa, Veronica, Aigner, Stefan, Vukcevic, Mirko, Sauter, Evelyn, Behr, Katharina, Ebeling, Martin, Dunkley, Tom, Friedlein, Arno, Zoffmann, Sannah, Meyer, Claas A., Knoflach, Frédéric, Lugert, Sebastian, Patsch, Christoph, Fjeldskaar, Fatiha, Chicha-Gaudimier, Laurie, Kiialainen, Anna, Piraino, Paolo, Bedoucha, Marc, Graf, Martin, Jessberger, Sebastian, Ghosh, Anirvan, Bischofberger, Josef, Jagasia, Ravi
Published in Cell reports (Cambridge) (05.04.2016)

Get full text

Journal Article

Agonist-activated Ca²⁺ influx occurs at stable plasma membrane and endoplasmic reticulum junctions

Agonist-activated Ca²⁺ influx occurs at stable plasma membrane and endoplasmic reticulum junctions

by Treves, Susan, Vukcevic, Mirko, Griesser, Johanna, Armstrong, Clara-Franzini, Zhu, Michael X, Zorzato, Fancesco
Published in Journal of cell science (01.12.2010)

Get full text

Journal Article

Ryanodine Receptor Activation by Cav1.2 Is Involved in Dendritic Cell Major Histocompatibility Complex Class II Surface Expression

Ryanodine Receptor Activation by Cav1.2 Is Involved in Dendritic Cell Major Histocompatibility Complex Class II Surface Expression

by Vukcevic, Mirko, Spagnoli, Giulio C., Iezzi, Giandomenica, Zorzato, Francesco, Treves, Susan
Published in The Journal of biological chemistry (12.12.2008)

Get full text

Journal Article

SRP-35, a newly identified protein of the skeletal muscle sarcoplasmic reticulum, is a retinol dehydrogenase

SRP-35, a newly identified protein of the skeletal muscle sarcoplasmic reticulum, is a retinol dehydrogenase

by Treves, Susan, Thurnheer, Raphael, Mosca, Barbara, Vukcevic, Mirko, Bergamelli, Leda, Voltan, Rebecca, Oberhauser, Vitus, Ronjat, Michel, Csernoch, Laszlo, Szentesi, Peter, Zorzato, Francesco
Published in Biochemical journal (15.01.2012)

Get more information

Journal Article

$Patient, caregiver, and physician preferences for treatment of relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)$

Patient, caregiver, and physician preferences for treatment of relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)

by Vukcevic, Mirko, Yung, Mallory, Khan, Maliha, Schnell, Frederick Mark
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

$Preferences and Perceptions Regarding Treatment Decision-Making for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)$

Preferences and Perceptions Regarding Treatment Decision-Making for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

by Yung, Mallory, Schnell, Frederick, Vukcevic, Mirko, Kurukulasuriya, Nuwan C.
Published in Blood (23.11.2021)

Get full text

Journal Article

$Poster: ABCL-405 Patient, Caregiver, and Physician Preferences for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)$

Poster: ABCL-405 Patient, Caregiver, and Physician Preferences for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

by Vukcevic, Mirko, Yung, Mallory, Khan, Mali, Houpt, Bethany, Schnell, Frederick
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)

Get full text

Journal Article

$ABCL-405 Patient, Caregiver, and Physician Preferences for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)$

ABCL-405 Patient, Caregiver, and Physician Preferences for Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

by Vukcevic, Mirko, Yung, Mallory, Khan, Mali, Houpt, Bethany, Schnell, Frederick
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)

Get full text

Journal Article

$Estimates of Survival and Life Expectancy with Tafasitamab Plus Lenalidomide in the L-Mind Study Compared with Real-World Standard-of-Care for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma$

Estimates of Survival and Life Expectancy with Tafasitamab Plus Lenalidomide in the L-Mind Study Compared with Real-World Standard-of-Care for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

by Duell, Johannes, Dreyling, Martin, Gaidano, Gianluca, Kalakonda, Nagesh, Gonzalez Barca, Eva Maria, Liberati, Anna Marina, Nagy, Zsolt, Moik, Daniel, Vukcevic, Mirko, Amin, Aasim, Bakuli, Abhishek
Published in Blood (02.11.2023)

Get full text

Journal Article

$Realmind: A Prospective and Retrospective Study to Characterize Real-World Use of Tafasitamab Plus Lenalidomide in US Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, with a Focus on Patients from Minority Groups$

Realmind: A Prospective and Retrospective Study to Characterize Real-World Use of Tafasitamab Plus Lenalidomide in US Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, with a Focus on Patients from Minority Groups

by Brem, Elizabeth A., Burke, John M., Vukcevic, Mirko, Kloepfer, Pia, Saverno, Kimberly, Abdulhaq, Haifaa, Evens, Andrew M, Porcu, Pierluigi, Shadman, Mazyar, Flowers, Christopher R.
Published in Blood (02.11.2023)

Get full text

Journal Article

$Realmind: A Prospective, Multicenter, Observational Study of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second- or Third-Line Therapy and Not Receiving Autologous Stem Cell Transplant$

Realmind: A Prospective, Multicenter, Observational Study of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second- or Third-Line Therapy and Not Receiving Autologous Stem Cell Transplant

by Flowers, Christopher R., Burke, John M., Vukcevic, Mirko, Snodgrass, Susan, Parasuraman, Shreekant, Büchele, Thomas, Kurukulasuriya, Nuwan C.
Published in Blood (23.11.2021)

Get full text

Journal Article

$Real-World Use of Tafasitamab for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the United States by Age Group (>70 Years and ≤70 Years)$

Real-World Use of Tafasitamab for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the United States by Age Group (>70 Years and ≤70 Years)

by Epperla, Narendranath, Nastoupil, Loretta J., Zimmerman Savill, Kristin M., Feinberg, Bruce, Galvin, John, Pathak, Prathamesh, Amoloja, Theresa, Vukcevic, Mirko, Saverno, Kim
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)

Get full text

Journal Article

$ABCL-206 Real-World Use of Tafasitamab for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the United States by Age Group (>70 Years and ≤70 Years)$

ABCL-206 Real-World Use of Tafasitamab for Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in the United States by Age Group (>70 Years and ≤70 Years)

by Epperla, Narendranath, Nastoupil, Loretta J., Zimmerman Savill, Kristin M., Feinberg, Bruce, Galvin, John, Pathak, Prathamesh, Amoloja, Theresa, Vukcevic, Mirko, Saverno, Kim
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)

Get full text

Journal Article

Minor sarcoplasmic reticulum membrane components that modulate excitation–contraction coupling in striated muscles

Minor sarcoplasmic reticulum membrane components that modulate excitation–contraction coupling in striated muscles

by Treves, Susan, Vukcevic, Mirko, Maj, Marcin, Thurnheer, Raphael, Mosca, Barbara, Zorzato, Francesco
Published in The Journal of physiology (01.07.2009)

Get full text

Journal Article

Frequent Calcium Oscillations Lead to NFAT Activation in Human Immature Dendritic Cells

Frequent Calcium Oscillations Lead to NFAT Activation in Human Immature Dendritic Cells

by Vukcevic, Mirko, Zorzato, Francesco, Spagnoli, Giulio, Treves, Susan
Published in The Journal of biological chemistry (21.05.2010)

Get full text

Journal Article

$ABCL-051 realMIND: A Prospective, Multicenter, Observational Study of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second/Third-Line Therapy and Not Receiving a Stem Cell Transplant$

ABCL-051 realMIND: A Prospective, Multicenter, Observational Study of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second/Third-Line Therapy and Not Receiving a Stem Cell Transplant

by Flowers, Christopher R., Burke, John M., Vukcevic, Mirko, Snodgrass, Susan, Saverno, Kim, Lumiqued, Mary Ann A., Abdulhaq, Haifaa, Brem, Elizabeth, Evens, Andrew, Farooq, Umar, Porcu, Pierluigi, Shadman, Mazyar
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)

Get full text

Journal Article

$Poster: ABCL-051 realMIND: A Prospective, Multicenter, Observational Study of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second/Third-Line Therapy and Not Receiving a Stem Cell Transplant$

Poster: ABCL-051 realMIND: A Prospective, Multicenter, Observational Study of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Starting Second/Third-Line Therapy and Not Receiving a Stem Cell Transplant

by Flowers, Christopher R., Burke, John M., Vukcevic, Mirko, Snodgrass, Susan, Saverno, Kim, Lumiqued, Mary Ann A., Abdulhaq, Haifaa, Brem, Elizabeth, Evens, Andrew, Farooq, Umar, Porcu, Pierluigi, Shadman, Mazyar
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)

Get full text

Journal Article

Increasing the number of diagnostic mutations in malignant hyperthermia

Increasing the number of diagnostic mutations in malignant hyperthermia

by Levano, Soledad, Vukcevic, Mirko, Singer, Martine, Matter, Anja, Treves, Susan, Urwyler, Albert, Girard, Thierry
Published in Human mutation (01.04.2009)

Get full text

Journal Article

Fibroblast growth factor 2 and platelet‐derived growth factor, but not platelet lysate, induce proliferation‐dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells

Fibroblast growth factor 2 and platelet‐derived growth factor, but not platelet lysate, induce proliferation‐dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells

by Bocelli‐Tyndall, Chiara, Zajac, Paul, Di Maggio, Nunzia, Trella, Emanuele, Benvenuto, Federica, Iezzi, Giandomenica, Scherberich, Arnaud, Barbero, Andrea, Schaeren, Stefan, Pistoia, Vito, Spagnoli, Giulio, Vukcevic, Mirko, Martin, Ivan, Tyndall, Alan
Published in Arthritis & rheumatology (Hoboken, N.J.) (01.12.2010)

Get full text

Journal Article

An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities

An RYR1 mutation associated with malignant hyperthermia is also associated with bleeding abnormalities

by Lopez, Rubén J, Byrne, Susan, Vukcevic, Mirko, Sekulic-Jablanovic, Marijana, Xu, Lifen, Brink, Marijke, Alamelu, Jay, Voermans, Nicol, Snoeck, Marc, Clement, Emma, Muntoni, Francesco, Zhou, Haiyan, Radunovic, Aleksandar, Mohammed, Shehla, Wraige, Elizabeth, Zorzato, Francesco, Treves, Susan, Jungbluth, Heinz
Published in Science signaling (05.07.2016)

Get more information

Journal Article